Company view · updated 2026-09-02

Regeneron Pharmaceuticals, Inc. (REGN)

What the Parallax research desks see on REGN right now - desk signals, the machine-learned score, and the latest analyst-team call.

Parallax Score machine-learned daily rank · 1-10 by decile

6/10

composite

momentum

trend

stability

$nan

last close

Drivers: pressing its 52-week high · strong 3-month run · beating the S&P over 3 months

Relative rankings within our liquid universe - descriptive, forward-tracked in the open, methodology here.

Across the desks 1 desk lit

Biotech catalyst

Each chip is an independent desk with live detail - insider filings, unusual flow, catalysts, retail chatter and more - visible to members.

Run the full analyst team on REGN. Four analyst desks gather the evidence, a bull and a bear debate it, a risk committee rules - and you get the entire debate, not just the verdict, in about three minutes. Free to start, no card.

Analyze REGN free →

Or read a full sample report first

Not ready for an account? Leave an email and we'll send the desk's featured analyses - starting with the next one that touches REGN.

Free desk previews: Options flow · Insiders & Congress · Biotech catalysts · Federal contracts · Confluence board

Automated, educational research - not investment advice, and not a recommendation to buy or sell any security.